Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MBX-7591: a promising drug candidate against drug-resistant fungal infections

mBio(2024)10.1128/mbio.01361-24Source: DataRank Database

MBX-7591: a promising drug candidate against drug-resistant fungal infections is a research paper published in mBio (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Maurizio Del Poeta ORCID,Nívea Pereira de Sá ORCID

Live enrichment

PubMed:38990019 PMC:PMC11323553 OpenAlex:https://openalex.org/W4400542341

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: AI116420

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: AI125770

U.S. Department of Veterans Affairs

Grant: IK6 BX005386

NIAID NIH HHS

Grant: R01 AI125770

NIAID NIH HHS

Grant: R01 AI116420

National Institutes of Health

Grant: 5R01AI116420-03

New antifungals targeting the synthesis of fungal sphingolipids

National Institutes of Health

Grant: 1IK6BX005386-01

BLRD Research Career Scientist Award Application

National Institutes of Health

Grant: 5R01AI125770-05

Lipid-mediated fungal pathogenesis

goldLicense: cc-by

journalhttp://dx.doi.org/10.1128/mbio.01361-24

publisherhttp://dx.doi.org/10.1128/mbio.01361-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.01361-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38990019

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11323553

Fields of Study

Antifungal resistance and susceptibilityFungal Infections and StudiesSynthesis and Biological Evaluation0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Invasive Fungal InfectionsAntifungal AgentsAspergillus fumigatusFungiHumansMicrobial Sensitivity TestsMycosesTriazolesDrug Resistance, Fungal

Keywords

AntifungalFungicideDrugAntifungal drugAntifungal drugsDrug resistanceMedicineBiologyPharmacologyIntensive care medicineMicrobiologyFatty acidMembraneAspergillus fumigatusFungal InfectionsDrug DevelopmentAntifungal AgentsFungiMicrobial Sensitivity TestsTriazolesQR1-502MycosesDrug Resistance, FungalCommentaryHumansInvasive Fungal Infections

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being